Galectin Therapeutics Inc — Balance Sheet (NASDAQ:GALT) | MetaTrader

Open full chart

Financials

Overview Rapor Statistics Dividends

Quarterly Annual

Total assets 29.6 M41.83 M21.29 M28.2 M17.5 M Total liabilities 5.41 M39.21 M53.48 M88.44 M120.56 M Total equity 22.47 M893 K33.92 M61.96 M104.79 M Total liabilities & shareholders' equities 29.6 M41.83 M21.29 M28.2 M17.5 M Total debt ————— Net debt —————

Haberler

Galectin Therapeutics yönetim kurulu üyesi Marc Rubin istifa etti

Galectin Therapeutics director Marc Rubin resigns from board

Galectin Therapeutics CFO’su 233 bin dolarlık hisse satışı gerçekleştirdi

Galectin Therapeutics CFO sells $233k in shares

Galectin Therapeutics: Runway With Convertible Financing But Dilution Overhang Remains

oracle, micron tech among market cap stock movers on friday

Galectin Therapeutics hisseleri FDA geri bildirimi sonrası sert düşüş yaşadı

Galectin Therapeutics stock plummets after FDA feedback on drug

FDA, Galectin’in belapectin geliştirme programı hakkında geri bildirim verdi

FDA provides feedback on Galectin’s belapectin development program

Galectin Therapeutics yöneticisi 1,05 milyon dolar değerinde hisse sattı

Galectin Therapeutics hissedarları yönetim kurulu üyelerini seçti ve önemli teklifleri onayladı